Biotech · Private company
Chinook Therapeutics, Inc. (formerly Aduro)
Track this companyFree. Adds Chinook Therapeutics, Inc. (formerly Aduro) to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ADU-S100Phase 2 · Metastatic Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- ADU-S100Phase 1 · Advanced/Metastatic Solid Tumors or LymphomasClinicalTrials.gov · fetched Nov 12, 2026
- ipilimumabPhase 1 · Advanced/Metastatic Solid Tumors or LymphomasClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck CancerPHASE2 · TERMINATED · started Aug 26, 2019ClinicalTrials.gov NCT03937141 · fetched Nov 12, 2026
- Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or LymphomasPHASE1 · TERMINATED · started Apr 28, 2016ClinicalTrials.gov NCT02675439 · fetched Nov 12, 2026